| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |